Showing results (201-210 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Experimental Medicine|March 9, 2005
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cellsHiroyoshi Nishikawa, Takuma Kato, Isao Tawara, et al.
Experimental Lung Research|December 22, 2011
A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG miceRebecca C Keith, Jennifer L Powers, Elizabeth F Redente, et al.
Transplantation|May 25, 2005
Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation toleranceJian-Guo Chai, Shao-An Xue, David Coe, et al.
Arthritis and Rheumatism|March 27, 2013
Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG miceRebecca C Keith, Jeremy Sokolove, Benjamin L Edelman, et al.
Cancer Immunology Research|December 19, 2015
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell LeukemiaYayoi Shimazu, Yutaka Shimazu, Masakatsu Hishizawa, et al.
American Journal of Clinical and Experimental Immunology|October 26, 2012
Pregnancy amelioration of arthritis in SKG mice corresponds with alterations in serum amyloid A3 levelsLaura A Shaw, Adrianne L Stefanski, Lisa K Peterson, et al.
Immunity|December 9, 2014
Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammationMasanori Matsumoto, Akemi Baba, Takafumi Yokota, et al.
Immunology|December 21, 2006
Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cellsSun K Lee, Beom K Choi, Young H Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signalsJun Mitsui, Hiroyoshi Nishikawa, Daisuke Muraoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humansDaisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, et al.
Pageof 32